The North America Automated Cell Counting Market would witness market growth of 11.5% CAGR during the forecast period (2023-2030).
Automated cell counters are statistical instruments utilized in pharmaceutical research, medical diagnostics, and food quality control to quantify and analyze cells. These employ sophisticated methodologies such as flow cytometry and digital imaging to facilitate meticulous and uniform cell examination. The market stands at the forefront of transformative advancements in life sciences, offering a pivotal range of sophisticated instruments and technologies that revolutionize cell analysis.
Automated cell counting represents a critical nexus between technological sophistication and the pursuit of more profound insights into cellular biology. These instruments encompass a diverse array of tools, from flow cytometers to image-based cell counters and automated haematology analysers, each designed to streamline and enhance the analysis of cells across various applications and industries. Defined by cutting-edge innovation, precision, and efficiency, this market caters to the burgeoning demands of scientific research, clinical diagnostics, pharmaceutical developments, and therapeutic innovations.
The increasing incidence of chronic ailments, including diabetes, cancer, and cardiovascular diseases, is a significant catalyst for expanding the market. Continuous monitoring and diagnosis of blood cell counts is necessary for chronic diseases, which increases the use of automated cell counters. According to the Centres for Disease Control and Prevention, the United States' fifth and first primary causes of death, respectively, are heart disease and stroke. Consequently, the increasing prevalence of chronic diseases in the region drives the demand in the market.
The US market dominated the North America Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,186.8 million by 2030. The Canada market is experiencing a CAGR of 14% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13% during (2023 - 2030).
Based on Product, the market is segmented into Consumables Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical Biotechnology Companies, Hospitals Diagnostic laboratories, Research Academic Institutes, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Automated cell counters are statistical instruments utilized in pharmaceutical research, medical diagnostics, and food quality control to quantify and analyze cells. These employ sophisticated methodologies such as flow cytometry and digital imaging to facilitate meticulous and uniform cell examination. The market stands at the forefront of transformative advancements in life sciences, offering a pivotal range of sophisticated instruments and technologies that revolutionize cell analysis.
Automated cell counting represents a critical nexus between technological sophistication and the pursuit of more profound insights into cellular biology. These instruments encompass a diverse array of tools, from flow cytometers to image-based cell counters and automated haematology analysers, each designed to streamline and enhance the analysis of cells across various applications and industries. Defined by cutting-edge innovation, precision, and efficiency, this market caters to the burgeoning demands of scientific research, clinical diagnostics, pharmaceutical developments, and therapeutic innovations.
The increasing incidence of chronic ailments, including diabetes, cancer, and cardiovascular diseases, is a significant catalyst for expanding the market. Continuous monitoring and diagnosis of blood cell counts is necessary for chronic diseases, which increases the use of automated cell counters. According to the Centres for Disease Control and Prevention, the United States' fifth and first primary causes of death, respectively, are heart disease and stroke. Consequently, the increasing prevalence of chronic diseases in the region drives the demand in the market.
The US market dominated the North America Automated Cell Counting Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,186.8 million by 2030. The Canada market is experiencing a CAGR of 14% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 13% during (2023 - 2030).
Based on Product, the market is segmented into Consumables Accessories, and Instruments (Image-based Cell Counters, Flow Cytometers, Electrical Impendence Coulter Counters). Based on Application, the market is segmented into Cell Line development, Blood Analysis, Stem Cell Research, and Others. Based on End-use, the market is segmented into Pharmaceutical Biotechnology Companies, Hospitals Diagnostic laboratories, Research Academic Institutes, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.), Thermo Fisher Scientific, Inc., Bio-Rad laboratories, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Olympus Corporation, Merck KGaA, Abbott Laboratories, Sysmex Corporation, and Agilent Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Consumables Accessories
- Instruments
- Image-based Cell Counters
- Flow Cytometers
- Electrical Impendence Coulter Counters
By Application
- Cell Line development
- Blood Analysis
- Stem Cell Research
- Others
By End-use
- Pharmaceutical Biotechnology Companies
- Hospitals Diagnostic laboratories
- Research Academic Institutes
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F.Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. North America Automated Cell Counting Market by Product
Chapter 6. North America Automated Cell Counting Market by Application
Chapter 7. North America Automated Cell Counting Market by End-use
Chapter 8. North America Automated Cell Counting Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Shanghai Ruiyu Biotechnology Co., Ltd. (Alit Biotech (Shanghai) Co., Ltd.)
- Thermo Fisher Scientific, Inc.
- Bio-Rad laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Olympus Corporation
- Merck KGaA
- Abbott Laboratories
- Sysmex Corporation
- Agilent Technologies, Inc.
Methodology
LOADING...
